Effects of hypoxia-inducible factor 1 on ischemic cerebrovascular disease

来源 :中国神经再生研究(英文版) | 被引量 : 0次 | 上传用户:whjsdsdsd
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Hypoxia-inducible factor I, a nuclear transcription factor, is induced by hypoxia. Hypoxia-inducible factor I, a heterodimeric DNA-binding protein, is composed of hypoxia-inducible factor 1α and hypoxia-inducible factor 1 β subunits, which are family members of the basic helix-loop-helix-PER, ARNT, SIM (PAS) protein. O2 concentration regulates hypoxia-inducible factor 1 activity via this subunit. Hypoxia-inducible factor 1α plays a major role in response to hypoxia and transcriptional activation, as well as in the target gene specificity of the DNA enhancer. Hypoxia-inducible factor 1β cannot be induced by hypoxia. This effect may be due to hypoxia-inducible factor 1 stability and activated conformation due to dimerization. Previous studies have shown that hypoxia-inducible factor 1 mRNA expression increases in the penumbra following ischemia/hypoxia. Hypoxia-inducible factor 1 plays an important role in brain tissue injury alter ischemia by affecting a series of target genes, elevating tolerance to hypoxia, and ensuring survival of neural cells. This article summarizes the structure, function, expression, regulatory mechanisms, biological effects, and significance of hypoxia-inducible factor 1 in patients with ischemic cerebrovascular disease. As a transcriptional activator, hypoxia- inducible factor 1 plays a key role in hypoxic responses by stabilizing the intal environment. It also has been shown to regulate the expression of several genes. The regulatory effects of hypoxia-inducible factor 1 in patients with ischemic cerebrovascular disease have been described. The present review re-examined the concept of brain protection at the level of gene regulation.
其他文献
BACKGROUND: It has been shown that irradiation to the neurolemma can reduce immunogenicity. However, it is still poorly understood whether the degenerated nerve
目的 分析学龄前儿童睡眠状况与情绪和行为问题的关联性.方法 200例学龄前儿童,采用儿童睡眠习惯问卷(CSHQ)、长处和困难问卷(SDQ)调查其睡眠状况与情绪和行为问题,并分析学
针对心绞痛发作频繁、疼痛持续时间延长或进行性加重而经一般抗心绞痛治疗效果不佳者18例,采取针药结合治疗,取得较好疗效,现报告如下:rn
目的 探讨阿托伐他汀治疗冠状动脉粥样硬化性心脏病(冠心病)并慢性心力衰竭患者的临床疗效.方法 70例冠心病并慢性心力衰竭患者,随机分为对照组与他汀组,各35例.对照组采取常
目的 观察倍他乐克缓释片对慢性心力衰竭(CHF)治疗前后血浆脑钠肽(BNP)及心功能的影响.方法 96例CHF患者,依照摸球法分为对照组和研究组,各48例.对照组给予常规治疗,研究组在
目的 探讨甲基强的松龙在重症哮喘并发呼吸衰竭患者临床治疗中的应用效果.方法 120例重症哮喘并发呼吸衰竭患者,随机分为观察组和对照组,每组60例.对照组患者采用常规治疗,观
BACKGROUND: Plasma fibrinogen (Fg) β-148C/T gene polymorphism is a risk factor for ischemic angiopathy.OBJECTIVE: To explore the frequency distribution of Fg
脾切除贲周血管离断术目前是治疗肝硬化门脉高压症的首选术式.门静脉血栓(PVT) 是术后不可忽视的重要并发症之一[1].术后PVT可导致肝功能进一步恶化,门静脉压力增高,甚者小
期刊